No. The FDA requested another bigger study they had previously indicated wouldn't be needed....and that from an opportunity cost perspective was worth delaying at the time. smart business decision.
Now they have tons of cash and growing revenues to support the bigger picture.
In the meantime they just keep adding products, running trials and are back in position to hit a homerun while hitting singles and doubles along the way.
News 
Market Data 
Discover 
